Withuspharmaceutical Coltd Stock EBITDA
| 330350 Stock | KRW 6,700 50.00 0.74% |
Withuspharmaceutical CoLtd fundamentals help investors to digest information that contributes to Withuspharmaceutical's financial success or failures. It also enables traders to predict the movement of Withuspharmaceutical Stock. The fundamental analysis module provides a way to measure Withuspharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Withuspharmaceutical stock.
Withuspharmaceutical |
Withuspharmaceutical CoLtd Company EBITDA Analysis
Withuspharmaceutical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Withuspharmaceutical EBITDA | 9.21 B |
Most of Withuspharmaceutical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Withuspharmaceutical CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Withuspharmaceutical CoLtd reported earnings before interest,tax, depreciation and amortization of 9.21 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The ebitda for all Republic of Korea stocks is 136.17% lower than that of the firm.
Withuspharmaceutical EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Withuspharmaceutical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Withuspharmaceutical could also be used in its relative valuation, which is a method of valuing Withuspharmaceutical by comparing valuation metrics of similar companies.Withuspharmaceutical is currently under evaluation in ebitda category among its peers.
Withuspharmaceutical Fundamentals
| Return On Equity | 6.62 | |||
| Return On Asset | 0.0664 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 101.14 B | |||
| Shares Owned By Insiders | 56.10 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Revenue | 57.42 B | |||
| Gross Profit | 32.33 B | |||
| EBITDA | 9.21 B | |||
| Net Income | 4.26 B | |||
| Cash And Equivalents | 13.83 B | |||
| Total Debt | 8.99 B | |||
| Debt To Equity | 0.22 % | |||
| Current Ratio | 3.64 X | |||
| Cash Flow From Operations | 8.02 B | |||
| Market Capitalization | 122.03 B | |||
| Total Asset | 118.98 B | |||
| Z Score | 7.8 | |||
| Net Asset | 118.98 B |
About Withuspharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Withuspharmaceutical CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Withuspharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Withuspharmaceutical CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Withuspharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Withuspharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Withuspharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Withuspharmaceutical Stock
| 0.94 | 102940 | Kolon Life Science | PairCorr |
| 0.83 | 074430 | Aminologics CoLtd | PairCorr |
| 0.75 | 023910 | Daihan Pharmaceutical | PairCorr |
| 0.61 | 047920 | HLB Pharmaceutical | PairCorr |
Moving against Withuspharmaceutical Stock
The ability to find closely correlated positions to Withuspharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Withuspharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Withuspharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Withuspharmaceutical CoLtd to buy it.
The correlation of Withuspharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Withuspharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Withuspharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Withuspharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Withuspharmaceutical Stock
Withuspharmaceutical financial ratios help investors to determine whether Withuspharmaceutical Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Withuspharmaceutical with respect to the benefits of owning Withuspharmaceutical security.